Melanoma Patient Recruitment in Delaware

TheraNovex connects clinical trial sponsors with pre-screened, eligible Melanoma patients across Delaware, including Wilmington, Dover, Newark, and beyond.

Melanoma clinical trial recruitment for BRAF-mutant, immunotherapy-naive, and advanced stage studies.

Who qualifies: Adults with Stage III–IV melanoma, including BRAF V600E/K mutation-positive patients.

Recruitment challenges: BRAF mutation status and prior immunotherapy exposure eligibility requirements.

Our approach: Dermatology and oncology referral networks, melanoma patient advocacy partnerships.

Our recruitment network spans all major metropolitan areas in Delaware, ensuring broad geographic coverage for your Melanoma trial.